Powered by Axial Data

Top Biotechnology Investment Banks

Explore 178 Biotechnology Investment Banks that leverage Axial’s platform to connect with investors on behalf of their clients.

Axial Insights

Biotechnology Investment Banks

178

Active Firms

224

TTM Deal Flow

$3M-$27M

Core Revenue Range

$500K-$5M

Core EBITDA Range


California 11%
Florida 8%
Texas 8%
New York 6%
Virginia 5%

Best For: Complex Transactions | Typical Fee: Retainer & Success fee | Coverage: Dedicated, Sector-Focused Deal Teams

Showing 101-120 of 178 Investment Banks

Sorted by recent activity

Warson Capital Partners is a St. Louis-based investment banking firm serving emerging growth companies and middle market companies nationwide. For more than 20 years, we have provided highly customized financial advisory services to these markets including:Capital Sourcing – equity and debt financingBridge Loan FinancingMergers & Acquisitions – sell-side and buy-side transactionsOther Financial Advisory Services including business strategy and planning, business valuations, due diligence, recaps, and distressed and work-out situations.We represent clients in first- and second-round…

Recent Transactions

This member has no reported closed transactions.

Davos Partners is a boutique investment bank headquartered in Denver, Colorado. We specialize in the discrete negotiation and management of transactions involving the sale or purchase of a private business enterprise. We work diligently to partner with entrepreneurs, ambitious business owners, and management teams to provide capital to grow existing lines, acquire new ones, buy-out existing owners and explore new frontiers.

Recent Transactions

This member has no reported closed transactions.

Corporate Finance Associates (CFA) is one of North America's oldest and most prominent investment banking firms serving middle-market companies. In its over 60 year history, CFA has recorded thousands of successful transactions by working diligently on the client’s behalf. Our global footprint and network of over 50 experienced professionals make CFA uniquely qualified to help you realize your business goals.Our mission is to provide services that give your company an edge in the M & A market place. The CFA team has the investment banking track record and exceptional…

Recent Transactions

This member has no reported closed transactions.

Objective, Investment Banking & Valuation (“Objective”) is a leading investment banking and valuation firm that services middle market companies within our industry practices: Business Services, Consumer, Healthcare Tech & Services, Life Sciences Services & Tech, Manufacturing & Distribution, and Technology. Within our industry practices we offer an investment banking group providing sell-side advisory, and a full-service valuation group providing tax compliance, financial reporting, transaction opinion, and…

Recent Transactions

This member has no reported closed transactions.

IG Private Company Advisory services encompass corporate finance (institutional private placements of debt and equity) and mergers and acquisitions advice. These investment banking services cater to middle-market firms with revenues ranging from $20 million to $1 billion.IG Private Company Adviosry is a part of IGM Financial Inc. is one of Canada's leading diversified wealth and asset management companies with approximately $271 billion in total assets under managements. The company provides a broad range of financial planning and investment management services to help more than two million…

Recent Transactions

This member has no reported closed transactions.

Stop Browsing. Start Transacting.

Join 20,000+ members who source deals, connect with counterparties, and close transactions on Axial.
We have been in the M & A sector for over 30 years with experience as investment bankers and as the Managing Director of P-Squared Management Enterprises, a Dalio family office funded lower-middle marked PE firm. At Roy Street Advisors we represent business owners, prospective buyers, and family offices in their quest to exit or acquire businesses with EBITDA of $1.0+ million.

Recent Transactions

This member has no reported closed transactions.

Victorem Group provides strategic advisory in the execution of mergers, sales, acquisitions, joint ventures, spin-offs, divestitures, and other restructurings. Our global M&A experience allows us to provide our clients' transaction opportunities all around the globe. Our network of contacts provides Victorem a competitive advantage over firms outside the region.STRATEGIC FINANCIAL PLANNING & ANALYSISVictorem’s extensive experience with global industries allows us to implement the best practices in order to assist our clients in the architecture of their short- and long-term…

Recent Transactions

This member has no reported closed transactions.

Independent capital markets advisor with specialty in debt advisory and placements of debt. Since 2007 advised on and placed over 30 transactions totaling nearly $900 million, with diversity around industries, commitment size, issue and structure.Specialties: Private Placements, ABL and Cash Flow Lending, Leveraged Buyouts, Mergers and Acquisitions, Capital FormationSecurities-related services provided by Burch & Company, Inc., member FINRA SIPC (www.finra.org www.sipc.org). Dark Horse Advisors LLC and Burch & Company, Inc. are unaffiliated entities. Any third party posts linked to…

Recent Transactions

This member has no reported closed transactions.

We are M&A Advisors for Privately-held CompaniesAllegiance Capital is an M&A advisory and investment banking firm that has been providing expert financial services to small and mid-sized, privately-held companies since 1998. Its specialty is representing privately-owned companies with annual revenues between $20 million and $500 million. Its clients are business owners, partners, families and entrepreneurs who want to sell their company, transition to new management, or bring on a financial partner to grow their business. Allegiance Capital also specializes in raising capital and facilitating…

Recent Transactions

View All
  • Aug 2014 Advised Insight Merchandising, Inc. in its sale to Hudson Ferry Capital
  • Jul 2014 Advised Lone Star Tank Rental in its sale to General Finance Corporation
  • Jun 2014 Advised Downing Wellhead Equipment, Inc. in its sale to Argonaut Private Equity
  • Feb 2014 Advised M&N Construction in its sale to APi Group, Inc.
Edgemont Capital Partners is a leading independent investment banking firm to the healthcare and life sciences industries. We focus on the needs of entrepreneurs, founders, owners and their investors of lower middle through middle market companies. We provide sell-side and buy-side mergers and acquisition advisory, restructuring advisory, board advisory and private placements services. Our world class transaction expertise is supported by a proven track record of success. We are a registered Broker / Dealer with FINRA and have advised on over 100 transactions representing more than $30…

Recent Transactions

View All
  • Dec 2017 Advised Clinical Research Institute of Southern Oregon on an investment from NaviMed Capital
  • Dec 2017 Advised New Horizons Clinical Research on an investment from NaviMed Capital
  • Nov 2017 Advised Brain Matters Research in its sale to Evolution Research Group
  • Jul 2017 Advised Endeavor Clinical Trials in its sale to Evolution Research Group
Greenwich Capital Group (“GCG") is a leading middle-market investment bank that advises clients including closely-held and family-owned businesses, private equity firms, and public companies. GCG’s senior bankers have collectively advised on hundreds of transactions and average nearly 20 years of experience in mergers and acquisitions, with most having backgrounds with large U.S. and global firms. GCG is focused on advising clients in key industry verticals throughout the U.S.GCG was founded by entrepreneurially minded investment banking professionals focused on building an organization…

Recent Transactions

View All
  • Aug 2024 Advised Alpha Metalcraft Group in its sale to Industrial Growth Partners
  • Jul 2024 Advised TopFlite Components in its sale to kSARIA Corporation
  • Apr 2024 Advised Venshure Test Services in its sale to AB Dynamics plc
  • Feb 2024 Advised Midwest Glass Fabricators, Inc. in its sale to Oldcastle BuildingEnvelope, Inc.

Berman Capital

37 Total Closed Deals
Berman Capital is dedicated to helping company owners and shareholders sell their business or raise capital for the highest possible price and the best possible fit for their employees, company, themselves and their families.Our experience proves this out: Since 1971 the principals at Berman Capital have completed over 70 multi-million-dollar merger & acquisition transactions working almost exclusively with private, entrepreneur driven companies. At Berman Capital, we pride ourselves on being a small, boutique FINRA regulated firm:- We focus on assisting mid-market companies (generating an…

Recent Transactions

View All
  • Jun 2015 Advised BAART in its sale to Webster Capital
  • Nov 2012 Advised Cal Saw Canada in its sale to A Strategic Partner
  • Feb 2011 Advised Laboratory Sales Limited in its sale to Wheaton Industries
  • Jun 2010 Advised Arvilla Oilfield Services in its sale to Select Energy Services
Commerce Street Capital, LLC, Member FINRA/SIPC, is a premier investment banking firm serving financial institutions and middle-market companies. We value collaboration with our client partners and enjoy building long term relationships established on a foundation of mutual respect, common goals, and uncommon integrity. Led by veterans of the financial industry, Commerce Street Capital’s practice includes: - Mergers & Acquisitions - Recapitalizations - Private Placement of Debt & Equity - Regulatory Advisory - Valuations & Fairness Opinions - Community Bank Capital Markets Services - SBIC…

Recent Transactions

View All
  • Sep 2015 Advised Schwertner State Bank in its sale to R Bank
  • Jul 2015 Advised Independent Bank of Texas in its sale to Veritex Community Banks
  • Jul 2015 Advised Vision Bank in its sale to Texas Bank and Trust
  • Jul 2015 Advised The Bank of Fayetteville in its sale to Farmers & Merchants Bank

Outcome Capital

28 Total Closed Deals
Outcome Capital is a unique investment banking firm that provides middle-market growth companies in the technology and life sciences markets with strategic value-added, client-centric approach to merger, acquisition and corporate finance advisory services.The firm utilizes its proven approach to value enhancement by assisting boards and management teams in navigating both the financial and strategic markets and in implementing the best path for success. Outcome Capital’s strength stems from its unique ability to draw on its wide range of operational, strategic and transaction experience,…

Recent Transactions

View All
  • Nov 2023 Advised Astellas in its sale to Propella
  • Oct 2023 Advised Health Catalyst in its sale to ERS
  • Jul 2023 Advised Fortune 500 in its sale to Innara Health
  • Dec 2020 Advised Sunstone Partners in its sale to Evergreen
Vista Point Advisors is a leading boutique investment bank focused on providing merger & acquisition and capital raising advisory services to founder-led middle-market companies in the Technology, Internet & Consumer Services, Software, SaaS and Cloud-Enabled Services, Mobile, Consumer Retail and Healthcare industries. The Company was founded on the principle that founder-led companies in the emerging and middle markets are unique and require specialized attention and advice when considering investment and exit opportunities. Vista Point works predominately as a sell-side advisor, which…

Recent Transactions

View All
  • Aug 2014 Advised Eckim in its sale to Coupons.com Incorporated
  • Apr 2014 Advised Axiom EPM in its sale to Kaufman Hall
  • Mar 2014 Advised Software Advice in its sale to Gartner
  • Nov 2013 Advised TechBargains.com in its sale to Ziff Davis Media

Landmark Ventures

14 Total Closed Deals
Landmark Ventures is a technology-focused investment banking and advisory practice. Landmark Ventures is highly focused and deeply experienced in managing complex transactions, including private placements, mergers and acquisitions, and strategic advisory assignments. Landmark’s industry focus and expertise spans the “Innovation Economy” (Technology, Digital Media, Internet, Software, Communications, Hardware, Cleantech, Healthcare and Medical Technology), with a core mandate of creating and maximizing enterprise value for our clients. We serve a diverse client base of entrepreneurs,…

Recent Transactions

View All
  • Jul 2023 Advised Minereye on an investment from SBI Holdings
  • Jul 2023 Assisted Triad Semiconductor in securing debt financing from Columbia Pacific Advisors
  • Jul 2023 Advised Northwell Health on an investment from Avanos
  • Apr 2023 Advised Fantasy Life in its sale to BETSPERTS
Concord Financial Advisors, LLC is a boutique investment banking and financial advisory firm serving public and private middle market companies in the United States. Concord specializes in private placements of senior debt and subordinated debt / mezzanine financing for companies requiring turnarounds, recapitalizations and growth. Private & Public Companies (Typically $20MM - $300MM in revenues) Private Equity Groups and their portfolio companies Family Businesses Entrepreneurs making acquisitions or seeking growth capital Financial Institutions looking to exit certain credit Manufacturing /…

Recent Transactions

View All
  • Jun 2014 Advised Scrap Metal Processor on an investment from Senior Secured Credit Facility
  • Dec 2013 Advised Secures $4,000,000 Million Senior Secured Credit Facility in its sale to Granite and Marble Distributor
  • Dec 2013 Advised $5 Million Cash Flow Term Loan in its sale to Pizza Franchisor
  • Dec 2013 Advised $7,000,000 Million Senior Secured Credit Facilities on an investment from Specialized Heavy Equipment Services Company
Aurum Capital Connect is a Denver- and Dallas-based investment bank and strategic advisory group that specializes in M&A and capital formation for middle market companies. We firmly believe active involvement with our client companies is key to success; we work closely with management teams to develop and execute strategy, open doors to capital, and create meaningful exits.

Recent Transactions

View All
  • Oct 2025 Advised HP EnviroVision on an investment from Confidential Company
  • Sep 2025 Advised Lion Fencing and Steel Supplies on an investment from Alterna Capital Partners
  • Jun 2025 Advised Encore Engineering Holdings on an investment from Confidential Company
  • Sep 2024 Advised Origins Lab in its sale to Montrose Environmental Group
Brooks, Houghton & Company, Inc. ("BHC") is a merchant banking firm dedicated to providing investment banking services and direct investment to middle market private and public companies, and emerging-growth companies. Formed in 1989, BHC emphasizes building long-term relationships with its clients by providing quality, innovative solutions to corporate finance needs, and recognizes the importance of relationships that are established through mutual trust and professional execution. BHC has expertise in manufacturing, specialty distribution and business services. Additionally, the firm has…

Recent Transactions

View All
  • Jul 2015 Assisted Mad Catz in securing debt financing from NewStar Business Credit LLC and Faunus Group International, Inc.
  • Jun 2015 Advised The Pharma Partners on an investment from Undisclosed
  • Dec 2014 Advised Confidential in its sale to Liberty Tile & Escrow Co
  • Oct 2014 Advised Confidential in its sale to Amax Incporated

Frequently Asked Questions

How are Investment Banks in this directory ordered?

Firms in the Biotechnology Investment Banks directory are ordered based on recent deal activity on Axial. The default order reflects observed market signals rather than a subjective ranking of firm quality.

What information is included in each Investment Bank profile?

Each profile provides information about the firm’s areas of focus, transaction criteria, and relevant activity on Axial’s M&A platform. Together, these details provide a clearer view of where a firm is active and the types of companies and opportunities most relevant for it.

What company sizes are most common for Biotechnology Investment Banks?

Based on activity on Axial’s M&A platform, the core revenue range for Biotechnology Investment Banks is $3M-$27M, with a core EBITDA range of $500K-$5M. Company size can be an important indicator of fit, as firms often concentrate their experience, resources, and transaction activity within particular segments of the market.

How important is Life Sciences experience when evaluating Investment Banks?

Relevant Life Sciences experience can be an important consideration when evaluating a firm. Familiarity with the sector can provide a stronger understanding of its business models, market dynamics, valuation considerations, and transaction environment. The 178 firms included in this directory provide a starting point for identifying firms with relevant experience and activity in Life Sciences.

Do all Investment Banks in this directory focus exclusively on Life Sciences?

Not necessarily. Many firms are active across multiple industries, so inclusion in the Biotechnology Investment Banks directory reflects relevant experience or activity in Life Sciences, rather than an exclusive sector focus. Individual profiles provide additional context on each firm’s areas of focus and activity within the sector.

How do I compare Investment Banks with experience in Life Sciences?

When comparing Investment Banks with experience in Life Sciences, consider factors such as size range, geographic reach, and recent transaction activity. These characteristics vary across the 178 firms included in the directory and can help identify firms that align with your needs.

How do I connect with Biotechnology Investment Banks?

Axial can help you identify and connect with firms based on your objectives and what you are looking to accomplish. The process varies depending on your role and transaction needs. If you are interested in connecting with firms in the Biotechnology Investment Banks directory, you can request information here.


Want to Keep Exploring?

Enter your details to access all firm profiles.

Let us curate Relevant Introductions.

Rather than a one-off introduction to company, work with an Axial Exit Consultant to find the best options from our network of 2,500 M&A advisors — at no cost to you.

Companies sold using Axial Advisor Finder:

Get Introduced to the Right Advisors

This service is complimentary and all information is confidential. Looking to learn more? Complete the form above.

By providing telephone number and submitting the form you are consenting to be contacted by SMS text message. Message & data rates may apply. Reply STOP to opt of further messaging.

We've Received Your Request

A member of our team will follow up to coordinate next steps.

Explore Axial
Template